浙江天台药业股份有限公司
Zhejiang Tiantai Pharmaceutical Co. Ltd.
Country: CN CDE+DMF+CEP VERY_HIGH
🇨🇳 CDE
5
7 products shown
🇺🇸 DMF
3
3 products shown
🇪🇺 CEP
4
4 products shown
Total
12
registrations
🇨🇳 CDE 注册 (7)
| Product | CAS | Status | Reg Number |
|---|---|---|---|
| Agomelatine 阿戈美拉汀 | 138112-76-2 | Class A | Y20240001220 |
| Amphotericin B 两性霉素B | 1397-89-3 | Class A | Y20230000538 |
| Clindamycin 克林霉素 | - | Class A | Y20240000312 |
| Clindamycin 克林霉素 | - | Class A | Y20190009736 |
| Clindamycin 克林霉素 | - | Class A | Y20190009612 |
| Vortioxetine 氢溴酸伏硫西汀 | 508233-74-7 | Class I | Y20260000296 |
| Zoliflodacin 盐酸佐利替尼 | - | Class A | Y20240001347 |
🇺🇸 DMF 注册 (3)
| Product | CAS | DMF Number | Date |
|---|---|---|---|
| Amphotericin B 两性霉素B | 1397-89-3 | 43575 | 2026-02-01 |
| Clindamycin Hydrochloride 盐酸克林霉素（供口服用） | 18323-44-9 | 20450 | 2007-03-28 |
| Clindamycin Phosphate 磷酸克林霉素 | 24729-96-2 | 17422 | 2004-05-09 |
🇪🇺 CEP 注册 (4)
| Product | CAS | CEP Number | Date |
|---|---|---|---|
| Amphotericin B, Process I 两性霉素B | 1397-89-3 | CEP 2023-150 - Rev 01 | 2025-05-14 |
| Amphotericin B, Process II, For Use In The Manufacture Of Parenteral Preparations 两性霉素B | 1397-89-3 | CEP 2023-152 - Rev 01 | 2025-10-06 |
| Clindamycin Hydrochloride 盐酸克林霉素（供口服用） | 18323-44-9 | CEP 2010-281 - Rev 04 | 2024-03-14 |
| Clindamycin Phosphate 磷酸克林霉素 | 24729-96-2 | CEP 2003-060 - Rev 07 | 2024-03-25 |
Source: cde+fda_direct; DMF高置信 | Updated: 2026-09-11 06:00:12